Objective: The maternally imprinted insulin-like growth factor 2 (IGF2) gene is an important fetal growth factor and is also suggested to have postnatal metabolic effects. In this study, we examined whether common polymorphisms in IGF2 (6815_6819delAGGGC, 1156T4C and 820G4A (ApaI)) and a microsatellite marker in the close vicinity of IGF2 were linked to or associated with birth weight and adult metabolic risk factors. Design and participants: Polymorphisms were genotyped in 199 monozygotic complete twin pairs, 109 dizygotic complete twin pairs, 15 single twins, 231 mothers and 228 fathers recruited from the East Flanders Prospective Twin Survey. Conventional and parent-of-origin specific linkage and association analyses were carried out with birth weight, adult body height and parameters quantifying obesity, insulin sensitivity and dyslipidaemia measured at adult age (mean age 25 years). Results: In the parent-of-origin specific association analysis, in which only the paternally inherited allele was incorporated, the 1156T4C SNP (single nucleotide polymorphism) showed significant association with IGF-binding protein 1 (IGFBP1) levels (T and C (mean (95% CI)): 13.2 (12.1-14.3) and 16.2 (14.6-18.0) ng ml À1 , P ¼ 0.002). No linkage was observed in either the conventional or in the parent-of-origin specific linkage analysis. Conclusion: This study suggests that paternally inherited alleles of a common polymorphism in the IGF2 gene affect IGFBP1 levels.
Introduction
The insulin-like growth factor 2 (IGF2) gene is a complex transcription unit located in the imprinted 11p15.5 chromosomal region. IGF2 is transcribed from five promoters (P0-P4) in a tissue-and development-specific way resulting in mRNA transcripts with different 5 0 untranslated regions that encode the same IGF2 preprohormone (see Figure 1) . 1, 2 In most human fetal tissues, IGF2 is primarily transcribed from the P3 promoter and exclusively paternally expressed, with the exception of specific regions in the brain where both the maternal and paternal alleles are transcribed. 3 In human liver, the major production source of circulating IGF2, the IGF2 gene is maternally imprinted during fetal life, whereas postnatally IGF2 is primarily transcribed from the P1 promoter, which is bi-allelicly active in the liver. 3, 4 In other adult tissues, including the heart, muscle, kidney and pancreas, IGF2 is mainly transcribed from the paternally active promoters. 2, 5 Experiments in mice showed that IGF2 is an important fetal growth factor, as inactivation of the paternal Igf2 allele results in significant growth retardation, whereas overexpression of Igf2 leads to fetal overgrowth. [6] [7] [8] In humans, low IGF2 expression levels due to epigenetic modifications have been observed in patients with the Silver-Russell syndrome, which is characterized by severe intrauterine and postnatal growth retardation. 9, 10 Conversely, overexpression of IGF2 due to different reasons is frequently observed in patients with the Beckwith-Wiedemann syndrome, which is a fetal overgrowth disorder. 10, 11 Although IGF2 is transcribed at a lower level after birth, several studies suggest that IGF2 may also have metabolic effects postnatally. For instance, transgenic mice overexpressing Igf2 in the adult liver were found to have an increased insulin-stimulated glucose uptake and a lower fat body mass. 12, 13 In addition, Kadlecová et al. 14 recently reported that a polymorphism in Igf2 strongly segregates with hypertriglyceridaemia in rats. In pigs, a paternally expressed quantitative trait locus (QTL), affecting muscle growth, fat deposition and size of the heart, was explained by a substitution in intron 3 of the IGF2 gene causing higher IGF2 mRNA expression in postnatal cardiac and skeletal muscle, but not in the liver. 15 Moreover, low levels of circulating IGF2 in human participants with normal glucose tolerance and in lean type 2 diabetes patients have been associated with an increased risk of future weight gain. 16, 17 As impaired fetal growth is a risk factor for adult metabolic diseases, 18 genes like IGF2 are attractive candidates to explain susceptibility to disorders such as T2D and obesity, and accordingly several association studies have been conducted. [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] In a sample of British middle-aged men, the minor allele of the 820G4A (ApaI) single nucleotide polymorphism (SNP) located in the 3 0 untranslated region of the IGF2 gene was associated with lower body mass, lower body mass index (BMI) and higher IGF2 levels. 20, 21 Although the association with lower BMI was replicated in an Israeli sample, 22 several studies failed to confirm this. [23] [24] [25] Moreover, a study in American participants even showed that minor allele carriers had a greater fat body mass. 26 In a follow-up of the UK study, Gaunt et al. 27 systematically sequenced all (un)translated exons and intron/exon boundaries of IGF2 and showed that three (6815A4T and 1156T4C in the 5 0 region, and 820G4A (ApaI)) out of eleven SNPs identified were independently associated with BMI. Recently, Heude et al. 28 failed to replicate these findings in 5000 middle-aged men and women, but did observe that these SNPs were significantly associated with body height. In addition, they reported that none of these SNPs were associated with birth weight, whereas in a Japanese sample minor allele carriers of the 820G4A (ApaI) SNP showed a significantly lower weight at birth. 29 In summary, the studies published thus far are inconclusive and none included parental genotypes. Furthermore, only two studies have examined the relation between IGF2 SNPs and indices of the carbohydrate and lipid metabolism. 21, 24 In this study, we genotyped the 6815A4T, 1156T4C, 820G4A (ApaI) SNPs and a microsatellite marker in the close vicinity of IGF2 in young adult twins and their parents; and we carried out conventional and parent-of- Figure 1 Schematic overview of the IGF2 gene region and the polymorphisms genotyped in this study (adapted from Monk et al. 2 and Rodriguez et al. 53 ). IGF2 comprises nine exons, eight introns and five promoters (P0-P4). Precursor IGF2 is encoded by the shaded exons. IGF2AS ¼ IGF2 antisense. *Sequencing showed that rs3842759 (6815A4T) is not an SNP but a 5-bp deletion (6815_6819delAGGGC).
The IGF2 gene region NY Souren et al origin specific linkage and association analyses with birth weight, adult body height, and parameters quantifying obesity, insulin sensitivity and dyslipidaemia.
Participants and methods

Participants
Twins and their parents were recruited from the EFPTS, which started in 1964 and has been recording all multiple births in the Belgian Province of East Flanders until the present. 30 
DNA extraction
For the twins, genomic DNA was initially extracted from available placental tissue collected at birth and/or twins were contacted and whole blood or mouth swabs were taken for DNA extraction. For the parents, mouth swabs were taken for DNA extraction. The DNA mini kit (Qiagen, Venlo, The Netherlands) was used for placental and mouth swab DNA extraction, the Wizard kit (Promega, Leiden, The Netherlands) was used for blood DNA extraction, both according to manufacturer's instructions. As there is a possibility that placental tissues were switched at birth within twin pairs, genotypes and phenotypes could possibly be combined incorrectly. To avoid false combinations, discordant genotypes within DZ pairs, of whom only DNA extracted from placenta tissue was available (43 individuals), were treated as missing values in the association analysis (o6% per SNP). Of the MZ twins, only one randomly selected member of a pair has been genotyped.
Genotyping
The 1156T4C SNP at nucleotide position 1156 in the GenBank sequence Y13633, the 6815A4T (rs3842759) and the 820G4A (ApaI) (rs680) SNP were selected for genotyping. Sequence analysis showed that the 6815A4T (rs3842759) variant in fact is a 5-bp deletion rather than a SNP. Therefore, we have renamed this variant 6815_6819de- Figure 1 . For the twins, the 1156T4C and the 820G4A (ApaI) SNPs were genotyped using pyrosequencing technology (Pyrosequencing AB, Uppsala, Sweden). PCRs were carried out in 15 ml mixes using 50-ng genomic DNA and 5 pmol of forward and reverse PCR primers (Eurogentec, Seraing, Belgium), 1 Â PCR buffer and 0.5 U of Taq polymerase (Invitrogen, Breda, The Netherlands). Primer information and PCR conditions are listed in Supplementary Table S2 . Pyrosequencing primers were designed using Pyrosequencing Primer SNP Design Version 1.01 software (http://techsupport. pyrosequencing.com). Pyrosequencing was carried out for sequence determination and allele designation in a PSQ HS 96A System (Pyrosequencing AB) according to the manufacturer's instructions.
For the parents, only very low amounts of DNA were available (derived from mouth swab extractions), and therefore the 1156T4C and the 820G4A SNPs were genotyped using the more sensitive SNaPshot assay. After amplification, the PCR products of both SNPs were pooled (2 ml of 820G4A and 3 ml of 1156T4C) and residual primers and unincorporated dNTPs were inactivated by incubating at 37 1C for 3 h with 1.66 U of Antarctic Phosphatase and 0.66 U of Exonuclease I (New England Biolabs, Leusden, The Netherlands), followed by an inactivation step of 20 min at 80 1C. The primers for single base extension were designed to anneal to the anti-sense strand immediately adjacent to the SNP. To avoid overlap between the final extension products, the length of the extension primers was modified by adding a non-homologous tail (Supplementary Table S2 ). SNaPshot reactions were carried out in 10 ml mixes containing 5 ml purified PCR product, 1 ml SNaPshot Ready Reaction Mix (Applied Biosystems, Nieuwerkerk a/d IJssel, The Netherlands), 1.6 ml pooled SBE primers and 2.4 ml water. Final primer concentrations were 0.4 mM for 820G4A and 0.25 mM for 1156T4C. Thermocycling conditions were 1 cycle of 1 min at 96 1C, 35 cycles of 10 s at 96 1C, 20 s at 50 1C and 30 s at 60 1C. Subsequently, extension products were incubated with 1 U of Shrimp Alkaline Phosphatase (ABgene, Surrey, UK) at 37 1C for 1 h, followed by 15 min at 75 1C. Purified extension product were size-resolved by capillary electrophoresis on the ABI3100 Genetic Analyzer (Applied Biosystems). Size calling was carried out with Genescan Software version 3.7 and the LIZ 120-size standard (Applied Biosystems).
For the 6815_6819delAGGGC and the D11S4046 microsatellite marker, fluorescently labeled primers were used to amplify the polymorphic DNA fragments (Supplementary The IGF2 gene region NY Souren et al Table S2 ). The five times diluted FAM-labeled products were size-resolved by capillary electrophoresis on the ABI3100 Genetic Analyzer (Applied Biosystems). Fragment length was determined relative to the ROX 350-size standard using the Genescan Software version 3.7 (Applied Biosystems).
General statistical analysis MERLIN was used to check for Mendelian errors. 32 A w 2 -test was used to check Hardy-Weinberg equilibrium for the genotype frequencies of the genetic markers in the parent and the twin sample (using only one randomly selected cotwin per pair). HAPLOVIEW was used to calculate linkage disequilibrium among the IGF2 SNPs. 33 
Conventional linkage analysis
To test for linkage between the IGF2 region and the quantitative traits, multipoint variance components linkage analysis was carried out using the statistical package MX. 34 In the models, phenotypic means were adjusted for significant covariates by modelling them as definition variables in the means model as previously described. 31 In the conventional variance components linkage analysis, phenotypic variation is decomposed into variance due to the QTL (Q), additive genetic (A, additive effects of genes on multiple loci), common environmental (C, environmental effects shared by twins reared in the same family) and unique environmental effects (E, environmental effects unique to the individual). As MZ twins are genetically identical, they are uninformative for linkage analysis. However, we included phenotypic data of MZ twins, as this will result in more accurate variance components estimates. For birth weight, the inclusion of phenotypic data of MZ monochorionic twins results in a reduced power to detect a QTL, 35 therefore only phenotypic data of the MZ dichorionic pairs were incorporated. Estimates of the variance component associated with the QTL were obtained using the pi-hat approach, in which the covariance due to the QTL for a sib-pair is modelled as a function of the proportion of alleles shared IBD. The proportion of marker alleles shared IBD between twins is defined by p k , where k refers to the kth twin pair. DZ twins may share 0, 1 and 2 alleles IBD, corresponding to p k ¼ 0, 0.5 and 1.0, respectively. The effect of the QTL in the conventional analysis was evaluated by comparing a full model, in which the genetic variance caused by Q for a given phenotype was free, with a restricted model, in which the effect of Q was equal to zero. Logarithm of the odds (LOD) scores, computed as the difference in À2log likelihood divided by 4.6, were used to evaluate the QTL effect.
Parent-of-origin specific linkage analysis
To asses the parent-of-origin effect, the variance due to the QTL needs to be partitioned into a component that reflects the QTL effect of the maternally derived chromosome (Q M ) and a component reflecting the QTL effect of the paternally derived chromosome (Q P ). In addition, the proportion of marker alleles shared IBD p k needs to be decomposed into a factor representing the proportion of maternal alleles shared IBD (p Mk ) and a factor representing the proportion of paternal alleles shared IBD (p Pk ). For DZ twins in a noninbred family, four IBD states are possible, {i M ,j M }{i P ,j P } (maternal and paternal alleles are shared IBD), {i M ,j M }{i P }{j P } (only maternal alleles are shared IBD), {i M }{j M }{i P ,j P } (only paternal alleles are shared IBD) and {i M }{j M }{i P }{j P } (no alleles are shared IBD), where i and j represent the members of a DZ twin pair, both carrying a maternally inherited allele (i M and j M ) and a paternally inherited allele (i P and j P ). The parentspecific identity by descent p Mk is calculated by summing the probabilities of {i M ,j M }{i P ,j P } and {i M ,j M }{i P }{j P }; and p Pk is calculated by summing the probabilities of {i M ,j M }{i P ,j P } and {i M }{j M }{i P ,j P }. p Mk and p Pk can be either 0.0 or 0.5, because
For the linkage analysis, the D11S4046 marker is the most informative marker. As the D11S4046 marker is also located close to the H19 gene (Figure 1 ), which is maternally expressed only, we evaluated the effect of both Q P and Q M . The effect of Q M (reported as LOD M ) was examined by comparing the full-imprinting model with a model in which Q M was equal to zero using the likelihood ratio w 2 -test with 1 df.
36 LOD M was calculated as the difference in À2log likelihood divided by 4.6. The effect of Q P was computed in the same way and reported as LOD P . In addition, the difference in fit between the non-nested full-imprinting model and the conventional linkage model was evaluated using the Akaike's Information Criterion. 37 Linkage analysis was carried out using a multipoint IBD estimate based on the genotypes of the microsatellite marker and the three SNPs, which then represents the IBD state of the IGF2 gene region. The probabilities of the different IBD states were estimated using MERLIN. 32 If parental genotypes were not available or not fully informative, then IBD states were estimated using allele frequencies computed using a sub-sample of one randomly selected co-twin per pair. As ignoring LD among the SNPs might overrate the IBD estimates (especially when parental data are missing), IBD estimates were calculated by taking marker-marker LD into consideration (r 2 40.10). Suggestive evidence for linkage was defined by LOD41 and significant evidence for linkage by LOD43.
Association analysis
Association between the IGF2 SNPs and the quantitative traits was determined using the PROC MIXED method implemented in the SAS package (version 9.1, SAS Institute Inc., Cary, NC, USA). A random intercept model was used, where the intercept of each twin pair was modelled as a function of the population intercept plus a unique contribution of the pair. In addition, the variance-covariance structure of the random intercept was allowed to differ between MZ and DZ pairs. For birth weight, the intra-pair
The IGF2 gene region NY Souren et al correlations differ between MZ monochorionic and MZ dichorionic twins. As data on chorionicity were available, the variance-covariance structure of the random intercept of birth weight was allowed to differ between MZ monochorionic, MZ dichorionic and DZ pairs. The paternally inherited allele together with significant covariates (see Supplementary Table S3 ) were incorporated into the random intercept model and association was tested using a 1 df F-test. In addition, genotypes based on both parental alleles were incorporated into the random intercept model, and a general association test (no assumption for mode of inheritance) was carried out using a 2 df F-test. An association was considered significant if Pp0.007. This significance threshold is adjusted for multiple testing, of which a detailed description is provided in the Supplementary material.
In case of positive associations, haplotype analyses were carried out by incorporating the haplotypes in the random intercept model. Haplotypes were reconstructed using FBAT. 38, 39 Only haplotypes that were unambiguously determined and having a haplotype frequency 410% were included in the haplotype analysis.
Results
Genotype and allele frequencies of the polymorphisms in the twins and their parents are listed in Table 1 . The allele frequencies of the D11S4046 microsatellite marker in the twins and their parents are presented in Supplementary  Table S5 . All genotype frequencies were in agreement with Hardy-Weinberg equilibrium (P40.05). In addition, the frequency distributions of the paternally inherited alleles are listed in Table 1 . As some families were uninformative, the total number of individuals from whom the paternally inherited allele was known is lower than the number of individuals from whom a genotype was available. The genotyping success rate for the 6815_6819delAGGGC, the 1156T4C SNP, the 820G4A SNP and the D11S4046 microsatellite marker was 0.99, 0.92, 0.98 and 0.96 in the twins and 0.99, 0.87, 0.91 and 0.96 in the parents, respectively (Table 1 and Supplementary Table S5 ). The genotyping error rate, based on 13 duplicates, was 0. The pairwise linkage disequilibrium statistics D 0 and r 2 were 0.62 and 0.09 for 6815_6819delAGGGC and 1156T4C, 0.49 and 0.21 for 6815_6819delAGGGC and 820G4A, and 0.22 and 0.01 for 1156T4C and 820G4A. The results of the univariate multipoint variance components linkage analysis with and without incorporating the parent-of-origin effect are presented in Supplementary Table  S6 . No significant or suggestive linkages were observed in either the conventional linkage analysis or in the parent-oforigin specific linkage analysis.
The results of the association analysis using the paternally inherited allele only are presented in Table 2 . A significant association was observed between the 1156T4C SNP and Abbreviations: GR, genotyping success rate; IGF2, insulin-like growth factor 2; n M , number of men in the whole sample (including both members of each twin pair); n W , number of women in the whole sample (including both members of each twin pair); P, parents; p HWE , P-value of the Hardy-Weinberg equilibrium test; S, sample; SNP, single nucleotide polymorphism; T, twins.
a As some families were uninformative, the paternal-derived allele could not always be determined. IGF2 haplotypes and paternally inherited haplotypes were unambiguously determined for 74.8% (463) and 59.8% (370) of all the individuals, respectively (Table 3) . Haplotype analysis was only carried out for IGFBP1 levels (taking only the paternally inherited haplotype into consideration). Two (wTG and wCG ) out of seven paternally inherited haplotypes had a frequency 410% (Table 3) . No significant association between these haplotypes and IGFBP1 levels was observed (wTG and wCG (mean (95% CI)): 16.4 (14.5-18.6) and 14.4 (12.8-16.2) ng ml
À1
, P ¼ 0.13).
Discussion
In this study, we carried out conventional and parent-oforigin specific linkage and association analyses to study the relation between the 6815_6819delAGGGC, the 1156T4C SNP, the 820G4A (ApaI) SNP and the D11S4046 microsatellite marker, located in the IGF2 gene region, with birth weight, adult body height and parameters quantifying obesity, insulin sensitivity and dyslipidaemia measured at adult age.
Although the genotype frequencies did not significantly deviate from Hardy-Weinberg equilibrium (P40.05), we observed for the 820G4A (ApaI) SNP in the parental sample a borderline insignificant P-value of 0.06. The most likely reason for deviation from Hardy-Weinberg equilibrium is genotyping errors. However, as no major Mendelian errors were detected, we interpret this borderline insignificant P-value as a chance finding. In addition, the observed genotype frequencies were similar to those reported in other Caucasian populations. 21, [23] [24] [25] [26] [27] [28] The 1156T4C SNP has thus far only been examined in two studies that reported conflicting genotype frequencies. 27, 28 Our genotype frequencies were in agreement with those reported by Heude et al.
28
The 6815_6819delAGGGC, the 1156T4C and the 820G4A (ApaI) SNPs have been independently associated with BMI in a large association study conducted by Gaunt et al. 27 Although in this study the 1156T4C SNP showed in the parent-of-origin specific association analysis a trend towards association with fat body mass (P ¼ 0.05), this result was considered non-significant after adjusting for multiple testing. Consequently, we could not replicate the findings of Geometric least squares mean (95% confidence interval). P-values lower than significance threshold are shown in boldface type and underlined. Data are expressed as least squares mean (95% confidence interval). 28 with adult body height. As our study has a smaller sample size, less power might explain these negative findings. In addition, Kaku et al. 29 found that the minor allele of the 820G4A (ApaI) SNP was associated with a lower weight at birth in a Japanese sample. 29 Neither this study nor the large study (n ¼ 5000) of Heude et al. 28 could replicate this association. These results might indicate that the association observed in the Japanese sample is a result of an ethnic-specific effect, for example, a functional rare variant in linkage disequilibrium with the 820G4A (ApaI) SNP.
In this study, we did observe a very interesting association with IGFBP1 levels, as carriers of the paternally inherited minor allele of the 1156T4C SNP had significantly higher IGFBP1 levels compared with carriers of the paternally inherited major allele (P ¼ 0.002). We also carried out a haplotype analysis using only the paternally inherited haplotype. This analysis revealed, however, no significant association (P ¼ 0.13), which is probably due to the lower power of the haplotype analysis compared with the association analysis. Interestingly, even though no significant or suggestive linkages were observed, the relation with IGFBP1 levels was visible in the linkage analysis. In this study, the fit of the conventional and the full-imprinting model was compared using the Akaike's Information Criterion (Supplementary Table S6 ). In case no effect is present, the conventional linkage model will always be preferred above the full-imprinting model (which is translated in a lower Akaike's Information Criterion), simply because the conventional linkage model uses 1 df less. However, IGFBP1 was the only phenotype for which the full-imprinting model had a better fit (lower Akaike's Information Criterion) compared with the conventional linkage model, attributable to the paternal chromosome. Nevertheless, the QTL effect was not significant, probably due to the small sample size of the linkage study (108 DZ twin pairs).
Taken together, this study provides evidence that a common polymorphism in IGF2 determines serum IGFBP1 levels. IGFBP1 is a member of the IGFBP family that modulates activity, bio-availability and tissue distribution of IGF1 and IGF2, of which IGF1 is besides insulin the most powerful peptide with a glucose-lowering effect. 40, 41 In total, there are six IGFBPs, but IGFBP1 is acutely downregulated by insulin and is suggested to be the short-term regulator of IGF1 bioactivity. [42] [43] [44] Low IGFBP1 levels predict the development of abnormal glucose regulation and have been associated with an unfavorable cardiovascular risk profile. 45, 46 Conversely, in patients with acute myocardial infarction and type 2 diabetes, high IGFBP1 levels have been associated with an increased risk of cardiovascular mortality and morbidity, which is probably the result of hepatic insulin resistance in these patients. 47 As circulating IGFBP1 is generally considered to be of hepatic origin, the effect observed in this study is possibly the result of a modified IGFBP1 expression mediated by IGF2 in the liver. This is in agreement with Lee et al. 48 who showed in human hepatoma cells that IGF2 is able to suppress IGFBP1 expression by binding to the IGF1 receptor (IGF1R). 48 Although IGF1R expression levels are low in the adult liver, 49 IGF2 can also bind to the insulin receptor that is abundantly expressed in the adult liver. 50, 51 Interestingly, in this study the association with IGFBP1 levels was only significant in the parent-oforigin specific analysis. This is surprising, as in the adult liver IGF2 is primarily transcribed from the bi-allelicly active P1 promoter. 4 However, in the adult liver IGF2 is also transcribed, although to a lower extent, from the paternally active P0, P2, P3 and P4 promoters. 2,4,52 Accordingly, the total expression level of the paternal IGF2 allele in the liver is higher than the expression level of the maternal IGF2 allele, which is probably translated in the detected parent-of-origin specific association. Interestingly, the paternally inherited minor allele of the IGF2 6815_6819delAGGGC variant showed a suggestive association with higher total and LDL-cholesterol levels (P ¼ 0.01 and P ¼ 0.02, respectively), which was already visible in the general association analysis (P ¼ 0.03 and P ¼ 0.05, respectively). To our knowledge, the (negative) studies of 't Hart et al. 24 and O'Dell et al., 21 who studied the relation between the 820G4A (ApaI) SNP and triglycerides and cholesterol levels, are the only association studies published thus far that examined the relation between a polymorphism in IGF2 and dyslipidaemia. However, our study is not the first study observing a relation between IGF2 and cardiovascular risk factors. A recently published study of Kadlecová et al. 14 reported that an insertion of 14 nucleotides in the Igf2 gene was associated with triglycerides levels in rats, and with cholesterol levels in male rats only. As ours is the first study reporting a (suggestive) association between an IGF2 polymorphism and cholesterol levels in humans, further studies are required to verify these findings. In summary, this study did not replicate previously reported associations between the 6815_6819delAGGGC, the 1156T4C and the 820G4A (ApaI) SNPs, with body height, BMI and birth weight. However, in this study the paternally inherited alleles of the IGF2 1156T4C SNP showed a significant association with serum IGFBP1 levels.
